ArticleBMC health services research2023

Cost-effectiveness analysis of imatinib versus dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia when combined with conventional chemotherapy in China.

Min Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.